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HealtHcare professionals are encountering more and 
more women with cardiac conditions contemplating preg-
nancy or when pregnant than ever before. Advances in 
surgical treatment of congenital cardiac anomalies mean 
many more women are now reaching childbearing age and 
contemplating pregnancy than would hitherto have been 
seen. 
Due to the fact that Irish figures have not been available 
thus far on the effects of cardiac disease on pregnancy and 
vice versa, we have come to rely on statistics from our near-
est neighbour the UK. The Centre for Maternal and Child 
Enquiries (CMACE) is an independent charity. Its mission 
is to improve the health of mothers, babies and children by 
carrying out confidential enquiries and other related work 
on a UK wide basis and widely disseminating the results. It 
produces a report every three years into maternal fatalities 
in the previous three-year period. The most recent report 
was published in 2007, reflecting the deaths that occurred 
in 2002-2005. In the most recent CMACE triennial report 
into maternal mortality (2002-2005) for the first time car-
diac disease was found to be the leading cause of maternal 
death among women in the UK, with a maternal mortality 
rate for heart disease of 2.27 per 100,000 maternities.1
It is interesting to note that in this triennium fewer women 
died from congenital cardiac disease than in previous 
reports. This may reflect improved pre-pregnancy counsel-
ling, improved methods of contraception or an improvement 
in the care provided for these women.1 
These figures available to us from CMACE only represent 
maternal mortalities and are from a jurisdiction where ter-
mination of pregnancy is an option for women. What are not 
captured are the figures on how many women with congeni-
tal heart conditions are actually getting pregnant but avail 
the option to terminate their pregnancies.
Changes in lifestyle, diet and exercise patterns have also 
seen an increase in the numbers of women presenting in 
pregnancy with acquired cardiac disease in recent times. 
Heart disease is the leading cause of death in Ireland with 
over 5,000 people dying from ischaemic heart disease 
(IHD) alone in 2007.2 However, the number of women of 
childbearing age (15-45 years) who died during 2007 is 
small n=437. Reassuringly, the World Health Organization 
quotes the maternal mortality rate in Ireland as very low 
at 1 per 100,000.3 This is encouraging considering the 
most recent Irish statistics show 70,620 births in Ireland 
for 2007.2 
The principal cause of maternal death in this report was 
found to be myocardial infarction (MI) followed by dissec-
tion of the thoracic aorta. The incidence of maternal death 
from MI is a rising trend over several reports.1 The authors’ 
suggestion is that these deaths reflect an underlying asso-
ciation between maternal mortality and modifiable lifestyle 
factors such as obesity. In only 29 of the 45 cardiac 
deaths catalogued was there was a body mass index (BMI) 
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recorded. Of these 29 women, 14 were found to be over-
weight (BMI>25) and 15 were obese (BMI>30), reflecting 
the scale of obesity as a comorbidity. What is clear from the 
report is that all of the women who died from IHD all had 
identifiable risk factors for MI. 
So morbidity, as well as mortality, should be of concern 
to healthcare professionals caring for pregnant women with 
co-existing cardiac disease. Again, in looking to the UK 
for recent statistics into maternal morbidity, the United 
Kingdom Obstetric Surveillance System Annual Report 
(UKOSS) cites an incidence of 0.6 cases of MI per 100,000 
maternities.4
irish statistics
As stated previously, statistics on the true extent of the 
mortality and morbidity surrounding cardiac disease and 
pregnancy in Ireland have been difficult to obtain and 
assess. In January 2009, Ireland joined the Centre for 
Maternal and Child Enquiries (CEMACE) in the UK. From 
that date on, Irish statistics will join with those from the 
UK to inform the next confidential enquiry into maternal 
deaths which, will be published in 2011. The statistics are 
collected by CEMACE Ireland at University College Cork/
Cork University Maternity Hospital under the directorship of 
Professor Richard Greene and his team. These figures then 
feed in with the UK statistics. CEMACE reports are very 
valuable in policy development; are widely disseminated 
and inform the multidisciplinary management and care of 
pregnant women. 
The National Perinatal Epidemiology Centre also based in 
UCC/CUMH is in the process of publishing Irish figures on 
maternal morbidity. They will provide invaluable informa-
tion on the Irish situation. 
a national registry 
What are the considerations for healthcare professionals 
who have contact with women of childbearing age who have 
pre-existing cardiac disease or those who may be at risk of 
acquired heart disease? These may include cardiologists, 
clinical nurse specialists, paediatricians, practice nurses, 
GPs and midwives.
The Royal College of Obstetricians and Gynaecologists 
(RCOG) has produced a document stating the consensus 
views arising from the 51st study group on Heart Disease 
and Pregnancy.5 It states the need for a national registry for 
the collation of data on pregnancy with heart disease. Due 
to the limited incidence of cardiac disease in pregnancy 
in any given country, a more global initiative was required. 
As a result, the European Society of Cardiology (ESC) has 
begun to collate such statistics through a Pregnancy and 
Heart Disease Registry.6
The objectives of the registry are to identify and quantify 
the incidence of heart disease in pregnant women through-
out Europe; to assess both the maternal and fetal mortality 
and morbidities associated with these pregnancies; to 
identify the rates of congenital heart disease; to assess 
the impact of pregnancy on maternal cardiac function; to 
identify the complications of the pregnancy itself and to 
compare different treatment modalities. At present I am 
unaware of any centre in Ireland contributing data to the 
registry; however several large European countries are.
education and counselling
The current literature from the Irish Crisis Pregnancy 
Agency informs us that anywhere from 16-54% of women 
may experience an unplanned pregnancy.7 This heightens 
the necessity to educate women about pregnancy, cardiac 
disease and the associated risks. This education may need 
to be provided to those with pre-existing cardiac disease 
while these girls are teenagers to reduce the likelihood of 
an unplanned pregnancy. Despite exhaustive efforts, I was 
unable to find out if anyone was providing this information 
in a structured manner in Ireland. As each case is unique, 
the onus of responsibility falls to every individual cardiolo-
gist to advise their patients based on the specific cardiac 
condition that they have. This information will need to 
be discussed with the consent of the girl’s parents also. 
CMACE (2007) advise that this vital component of care 
should take place at timely manner and should not be 
postponed until the girl has been transferred to the adult 
cardiologist service. Clinical nurse specialists could prove 
invaluable in providing a key function in respect of patient 
education. However it is important to stress that the major-
ity of maternal mortalities reported are in women who have 
never been identified as being ‘at risk’.5 
The majority of women with cardiac complications will 
have a favourable outcome in pregnancy.8 However the risks 
are ever present. Even women in New York Heart Associa-
tion (NYHA) class I and II may not have good outcomes. 
This can be because the normal physiological changes in 
the cardiovascular system in pregnancy may result in prob-
lems for previously asymptomatic women with, eg. mitral 
or aortic stenosis. Nevertheless, there are certain cardiac 
conditions where the risk to the mother is so great that 
pregnancy should definitely be discouraged. These include 
pulmonary vascular disease; fragile aortas, eg. Marfan’s 
syndrome; left-sided obstruction; poorly functioning left 
ventricle or any woman in NYHA class III or IV.8 Difficulties 
can arise because these women are less able to cope with 
the superimposed complications of pregnancy. It is because 
obstetricians and cardiologists see so few of these women 
annually that the ESC is hoping to improve outcomes as a 
result of the previously mentioned registry. The 
RCOG5 stresses the need for tailored contraceptive advice 
and the need for speedy access to emergency contraception 
if unprotected sexual intercourse has occurred. It also states 
that ‘urgent access to termination of pregnancy should be 
readily available’. This is not an option for women currently 
in Ireland; however Irish doctors are able to provide infor-
mation to women on this option and its availability in other 
jurisdictions without risk of censure.9 
antenatal care
A multidisciplinary approach is the option of choice for 
women with pre-existing cardiac disease once pregnancy 
is confirmed. This includes obstetricians, cardiologists, 
anaesthetists, general practitioners, dieticians and mid-
wives. The frequency of antenatal visits will need to be 
adjusted upwards. 
Antenatal care should take place where there is suit-
able equipment and trained staff available for antenatal 
screening, eg. ultrasound scanning to detect any fetal 
abnormalities. CMACE1 recommends extra consideration 
should be given to immigrant women who may not have 
had childhood screening available to them and who are at 
greater risk of undiagnosed cardiac disease. 
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intrapartum care
A tertiary level hospital should be the place of choice 
for the birth. The principle of care should be to promote 
normality where possible and to reduce any strain on the 
cardiovascular system. To these ends, spontaneous vaginal 
birth is preferred with low dose epidural. Limiting the exer-
tion of the second stage of labour by use of an instrumental 
birth, eg. forceps or vacuum may be advised to reduce 
undue cardiac strain. 
Induction of labour may be necessary due to deteriorating 
maternal condition but this should be balanced against the 
increased risks of operative birth in women less than 41 
weeks gestation.5 
postnatal care
Surveillance is important during and following birth, par-
ticularly during and immediately following the third stage 
of labour to avoid hypotension and hypertension from utero-
tonic agents.10 The woman’s condition in the immediate 
postnatal period requires close monitoring due to the initial 
risk of fluid overload as a result of uterine tonicity. Multi-
disciplinary observation should continue until the woman’s 
condition is stable and she may be discharged.5
acquired heart disease
Sixteen women died from ischaemic heart disease (IHD) 
in the last reported triennium. This figure was double 
that in the previous report.1 All of the 16 women who 
died from MI or IHD had identifiable risk factors. They 
included obesity, hypertension, smoking, family history 
and type 2 diabetes. There was also a higher mortality 
rate among older mothers, particularly when comparing 
those women with acute MI to those without. The report 
also highlighted the fact that healthcare professionals 
were failing to recognise the classical symptoms of acute 
myocardial infarction, ie. crushing, radiating chest pain 
or ECG changes. The report’s author recommends a low 
threshold for investigation of such pain, particularly in 
women with identifiable risk factors for IHD. Another 
noteworthy point is that MI may present with uncommon 
symptoms in pregnancy such as abdominal or epigas-
tric discomfort with or without vomiting.1 Appropriate 
investigations should be instigated in light of identifi-
able risk factors in women presenting with chest pain. 
These include, though not exhaustive, ECG, CXR, cardiac 
enzymes (Troponin), echocardiography and CT pulmonary 
angiography.  
Joint decision
The decision to plan a pregnancy is one that a woman 
with cardiac disease should make following discussion with 
her cardiologist and others in the multidisciplinary team. 
Once a woman has made the decision to proceed with a 
pregnancy she should be supported by the multidisciplinary 
team to strive to achieve the optimal fetal and maternal 
outcome. 
Women with identifiable risk factors for IHD should be 
screened pre-conceptually where possible and counselled 
accordingly to minimise their modifiable risk factors. Any 
risk factors should be identified antenatally and care tai-
lored to reduce the potential for complications in these 
women. Healthcare professionals caring for pregnant 
women should be aware that the risk factors for IHD and 
MI apply to pregnant woman as much as they do to the rest 
of the population. 
Vigilance should be the key word when dealing with 
symptoms of IHD and MI in otherwise apparently healthy 
pregnant women. In conjunction with improved awareness, 
education and care, the data gathered by NPEC, CMACE 
Ireland and the Euro Heart Survey on Pregnancy will help 
improve care for all pregnant women with and at risk from 
cardiac disease. 
 
Margaret M Murphy is a lecturer/practitioner in Midwifery 
at the catherine Mcauley school of nursing and Midwifery, 
University college cork
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